Veracyte | VCYT - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Agenus USD 249.24M 74.25M 2026-03
Agilent USD 2.23B 113M 2025-12
Anika Therapeutics USD 20.97M 942K 2026-03
Arrowhead Research USD 295.22M 52.2M 2026-03
Bruker USD 1.36B 75.9M 2026-03
Heron Therapeutics USD 90.52M 5.58M 2026-03
Illumina USD 1.57B 19M 2026-03
Intrexon USD 23.02M 38K 2024-06
Karyopharm Therapeutics USD 92.06M 4.9M 2025-12
Laboratory Of America USD 2.64B 182.5M 2026-03
Ligand Pharmaceuticals USD 40.67M 3.22M 2026-03
Myriad Genetics USD 130.2M 3.6M 2026-03
Rigel Pharmaceuticals USD 94.4M 7.76M 2025-09
Roche Holding CHF 28B 421M 2025-12
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Siemens EUR 49.52B 168M 2026-03
Sonic Healthcare AUD 2.23B 92.84M 2024-12
Thermo Fisher Scientific USD 14.62B 568M 2026-03
Veracyte USD 56.11M 3.82M 2026-03
Waters USD 1.24B 11.8M 2025-12